Eccrine porocarcinoma (EP) is believed to arise from the intraepithelial portion of the eccrine sweat glands. Th e incidence rate of EP is reported to be 18 per 450,000 biopsies. Most of the diagnosed cases involve the lower extremities; a case of EP involving the ear is rare. We describe the clinical, radiologic, and histopathologic features of EP in an 11-year-old boy.
Introduction
Tumors arising from sweat glands represent approximately 1% of all primary skin lesions. 1 Eccrine porocarcinoma (EP) is believed to arise from the intraepithelial portion of the eccrine sweat gland. Initially described by Goldman in 1956, 1 EP is exceedingly rare and comprises only 0.005% of cutaneous tumors. 2 Most cases of EP involve the lower extremities, and EP involving the ear is extremely rare. We present a case of EP in the external auditory canal.
Case report
A healthy 11-year-old boy presented to his primary care physician with a 3-week history of "swimmer's ear. " He had subjective complaints of decreased hearing and occasional spontaneous bleeding from his right ear. He was treated by his primary care physician with topical ear drops without improvement.
Upon the patient's referral to our ENT department, clinical examination of his right ear revealed a vascularappearing, multilobulated mass completely occluding the right external auditory canal. Conductive hearing loss in the right ear was confi rmed by audiometry.
Computed tomography (CT) with contrast showed an unusual lesion centered in the right external ear canal, extending or bulging into the middle ear (fi gure 1). Magnetic resonance imaging (MRI) showed an enhancing heterogeneous mass extending medially from the external auditory meatus into the middle ear to the cochlear promontory, with the anterior and inferior borders reaching the parotid gland. Many of the right mastoid air cells were opacifi ed. All osseous structures and the margins of the right external auditory canal were intact. Inner ear structures were normal in appearance. An angiogram showed the right internal carotid artery to be separate from the mass, and there was no evidence to suggest communication with the adjacent extracranial soft tissues or other vasculature.
A transcanal biopsy was done under general anesthesia. Frozen sections indicated large islands of poroid cells with multiple surface connections and angulated irregular nests with an infi ltrative appearance (fi gure 2, A). Focal ductal diff erentiation was noted (fi gure 2, B). Keratin cocktail immunostains did not support the presence of a sarcomatoid component. Th e patient was diagnosed with EP of the right external auditory canal.
Aft er permanent pathology was available, the patient subsequently underwent a right selective neck dissection, parotidectomy, wide excision of the external ear canal with radical mastoidectomy, and skin graft reconstruction.
Discussion
In the EP cases reported in the literature, signifi cant dissimilarities in patient characteristics and clinical fi ndings are apparent. Th e literature does not support a clear predilection of gender. Th e average age of patients at the time of diagnosis ranges from 50 to 80 years, and very few cases of EP have been documented in the literature in patients younger than 18 years. 3 Duration of an EP lesion is widely variable. Patients may have symptoms for years and even decades prior to diagnosis. patterns recognized as invasive with cytologic atypia are also indicators of poor prognosis. Other malignant features include cytoplasmic pleomorphisms, abnormal mitotic fi gures, and DNA aneuploidy.
Low-grade EP tumors have no signs of necrosis, low mitotic activity, and only slight nuclear pleomorphism. A clear cell variation also exists. Th is distinct variant consists of cells containing glycogen in the cytoplasm and may be associated with diabetes. Tumor cells may express carcinoembryonic antigen and epithelial membrane antigen; however, neither has been shown to be expressed in 100% of tumors. 8 Genetically, p53 oncogene expression is seen in 88% of EP cases. 8 Th e duration of the presence of the tumor may correlate with p53 positivity, which may be a sign of early malignant transformation. Documentation of overexpression of the p16 gene and loss of the retinoblastoma protein have also been noted; however, these are inconsistent and not diagnostic. 8, 9 Th e treatment of EP is wide local excision. Currently there are no standards for treatment based upon the size of the lesion. Despite excision, there is a 20% recurrence rate. 10 Mohs surgery has been utilized and may be associated with a slightly lower rate of recurrence, but there are very few case reports at this time. 10 Radiation therapy has been used and has shown limited benefi t. Multiple chemotherapy regimens, including cyclophosphamide, bleomycin, cisplatin, and 5-fl uorouracil, have been used Conversely, as in our patient, some lesions appear to become symptomatic aft er a short duration.
EP may develop in any area where eccrine sweat glands are present, either de novo or in a preexisting lesion, and many EP tumors are believed to arise from antecedent poromas. 3 Of all diagnosed cases of EP, the majority are found on the lower extremities, and a diagnosis of EP involving the ear is rare. 4 Clinically, these lesions are usually 1 to 5 cm in size with a verrucous plaque or polypoid appearance, while cutaneous metastases present as skin-colored or purple papules. 5 Th e incidence rate for EP is reported to be 18 per 450,000 biopsies. 3 Th e recurrence rate is approximately 20%, and the mortality rate is greater than 50%. 6 Metastasis to lymph nodes occurs in 20% of cases, with lymphovascular invasion in 15% of cases; metastasis to distant organs occurs in 10% of cases. 3 Tumor penetration >7 mm is associated with a more aggressive clinical course and a poor prognosis. 3 Neither CT nor MRI has any utility in diagnosis; however, both have been used to evaluate tumor extension and local or diff use lymphadenopathy. Positron emission tomography (PET) studies have been used eff ectively to detect recurrent tumor or malignancy. Nodular histologic subtypes and tumors >2 cm are more likely to test positive on a PET scan which, therefore, may be considered for initial patient work-up for staging or evaluation for suspicion of recurrence. 7 Th e diagnosis of EP is based on microscopic fi ndings. It is a poorly diff erentiated, diff usely infi ltrating tumor originating from cells of the outer layer of the acrosyringium and upper dermal eccrine duct. Microscopically, atypical cells with ductal structures and intracytoplasmic lumina extend throughout the entire thickness of the epidermis, with minimal invasion into the dermis. Approximately 10 to 15% of EP tumors are in situ. 3 Acrosyringeal diff erentiation is recognized by the presence of multiple lumina lined with a cuticular border, which is a prerequisite for diagnosis. While acrosyringium is a structure that may aid in diagnosis, it may be absent in ulcerated lesions.
Histopathologically, EP cells are noted to be hyperchromatic and multinucleated, with irregularly shaped nuclei and an invasive growth pattern. Tumor cells are periodic acid-Schiff -positive with diastase digestible granules in the cytoplasm. Juxtadermally located tumors grow horizontally and may produce pagetoid infi ltration in the overlying epidermis. Epidermotropism, high mitotic activity, and lymph node involvement may be present and are considered poor prognostic indicators. Growth with varying success. Interferon and interleukin-2 have shown promising results and, when combined with paclitaxel, have shown long-term disease stability. Th ere currently are no protocols for radiation or adjuvant chemotherapy. 11 Despite adjuvant therapy, two-thirds of patients die of metastatic disease. Without treatment, patients have an average lifespan of 5 to 24 months.
In conclusion, EP is an aggressive, malignant tumor that may involve the ear. Careful evaluation and biopsy of any suspicious lesions should be performed. 
